Department of Psychology, Sigmund Freud University, Milan, Italy.
Department of Health Sciences, University of Florence, Florence, Italy.
Clin Psychol Psychother. 2022 Nov;29(6):1972-1990. doi: 10.1002/cpp.2767. Epub 2022 Jul 9.
The COVID-19 Anxiety Syndrome Scale (C-19ASS) is a quick and reliable scale assessing dysfunctional coping strategies activated in response to COVID-19 fear and threat. The present study aimed to provide a preliminary validation of the Italian version of the C-19ASS and investigated whether the C-19ASS would mediate the relationship between the Big Five personality traits and psychological outcomes.
In Study 1, a community sample of 271 participants completed the Italian version of the C-19ASS and results were subjected to a Principal Component Analysis. In study 2, a community sample of 484 participants completed the Italian version of the C-19ASS and a series of measures assessing COVID-19 anxiety, COVID-19 fear, functional impairment, personality traits, depression, generalized anxiety and health anxiety. Internal consistency, concurrent and incremental validity were assessed. Path analyses were run.
Factor analysis identified a two-factor solution (i.e., C-19ASS Perseveration and C-19ASS Avoidance) and confirmatory factor analysis suggested a two-factor model best fits the data. The Italian version of the C-19ASS showed good internal consistency. There was also evidence of convergent validity and incremental validity. Path analyses showed that C-19ASS Perseveration mediates the relationship between emotional stability and psychological symptoms (depression, generalized anxiety and health anxiety).
The Italian version of the C-19ASS appears to be a reliable and valid measure of the COVID-19 anxiety syndrome. The COVID-19 anxiety syndrome could be a suitable therapeutic target to reduce psychological symptoms typically linked to pandemic events, such as depression generalized anxiety and health anxiety.
COVID-19 焦虑综合征量表(C-19ASS)是一种快速可靠的量表,用于评估应对 COVID-19 恐惧和威胁时出现的功能失调应对策略。本研究旨在对 C-19ASS 的意大利版本进行初步验证,并探讨 C-19ASS 是否会在大五人格特质与心理结果之间起中介作用。
在研究 1 中,271 名社区参与者完成了 C-19ASS 的意大利版本,结果进行了主成分分析。在研究 2 中,484 名社区参与者完成了 C-19ASS 的意大利版本和一系列评估 COVID-19 焦虑、COVID-19 恐惧、功能障碍、人格特质、抑郁、广泛性焦虑和健康焦虑的措施。评估了内部一致性、同时和增量有效性。进行了路径分析。
因素分析确定了两因素解决方案(即 C-19ASS 坚持和 C-19ASS 回避),验证性因素分析表明两因素模型最适合数据。C-19ASS 的意大利版本具有良好的内部一致性。也有证据表明具有收敛有效性和增量有效性。路径分析表明,C-19ASS 坚持在情绪稳定性与心理症状(抑郁、广泛性焦虑和健康焦虑)之间起中介作用。
C-19ASS 的意大利版本似乎是 COVID-19 焦虑综合征的可靠有效测量工具。COVID-19 焦虑综合征可能是一个合适的治疗靶点,可以减轻与大流行事件相关的心理症状,如抑郁、广泛性焦虑和健康焦虑。